77 participants
A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-30
- Start Date:
- 2024-12-11
- Completion:
- 2030-12-31
Conditions
- LOCALLY ADVANCED CERVICAL CANCERS
Interventions
- COMBINATION_PRODUCT
- OTHER
No Results Yet